Adult ewing sarcoma

Survival and local control outcomes in 102 patients with localized disease

Safia K. Ahmed, Steven Robinson, Scott Heitaka Okuno, Peter S. Rose, Nadia N Laack

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives. To assess the clinical features and local control (LC) outcomes in adult patients with localized Ewing Sarcoma (ES). Methods. The records of 102 ES patients with localized disease ≥18 years of age seen from 1977 to 2007 were reviewed. Factors relevant to prognosis, survival, and LC were analyzed. Results. The 5-year overall survival (OS) and event-free survival (EFS) were 60% and 52%, respectively, for the entire cohort. Treatment era (1977-1992 versus 1993-2007) remained an independent prognostic factor for OS on multivariate analysis, with improved outcomes observed in the 1993-2007 era (P = 0.02). The 5-year OS and EFS for the 1993-2007 era were 73% and 60%, respectively. Ifosfamide and etoposide based chemotherapy and surgery were more routinely used in the 1993-2007 era (P < 0.01). The 5-year local failure rate (LFR) was 14%, with a 5-year LFR of 18% for surgery, 33% for radiation, and 0% for combined surgery and radiation in the 1993-2007 era (P = 0.17). Conclusion. Modern survival outcomes for adults with localized ES are similar to multi-institutional results in children. This improvement over time is associated with treatment intensification with chemotherapy and increased use of surgery. Aggressive LC (combined surgery and radiation) may improve outcomes in poor prognosis patients.

Original languageEnglish (US)
Article number681425
JournalSarcoma
Volume2013
DOIs
StatePublished - 2013

Fingerprint

Ewing's Sarcoma
Survival
Radiation
Disease-Free Survival
Drug Therapy
Ifosfamide
Etoposide
Multivariate Analysis
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Adult ewing sarcoma : Survival and local control outcomes in 102 patients with localized disease. / Ahmed, Safia K.; Robinson, Steven; Okuno, Scott Heitaka; Rose, Peter S.; Laack, Nadia N.

In: Sarcoma, Vol. 2013, 681425, 2013.

Research output: Contribution to journalArticle

@article{f017507341c6462096cdf400db6e13ea,
title = "Adult ewing sarcoma: Survival and local control outcomes in 102 patients with localized disease",
abstract = "Objectives. To assess the clinical features and local control (LC) outcomes in adult patients with localized Ewing Sarcoma (ES). Methods. The records of 102 ES patients with localized disease ≥18 years of age seen from 1977 to 2007 were reviewed. Factors relevant to prognosis, survival, and LC were analyzed. Results. The 5-year overall survival (OS) and event-free survival (EFS) were 60{\%} and 52{\%}, respectively, for the entire cohort. Treatment era (1977-1992 versus 1993-2007) remained an independent prognostic factor for OS on multivariate analysis, with improved outcomes observed in the 1993-2007 era (P = 0.02). The 5-year OS and EFS for the 1993-2007 era were 73{\%} and 60{\%}, respectively. Ifosfamide and etoposide based chemotherapy and surgery were more routinely used in the 1993-2007 era (P < 0.01). The 5-year local failure rate (LFR) was 14{\%}, with a 5-year LFR of 18{\%} for surgery, 33{\%} for radiation, and 0{\%} for combined surgery and radiation in the 1993-2007 era (P = 0.17). Conclusion. Modern survival outcomes for adults with localized ES are similar to multi-institutional results in children. This improvement over time is associated with treatment intensification with chemotherapy and increased use of surgery. Aggressive LC (combined surgery and radiation) may improve outcomes in poor prognosis patients.",
author = "Ahmed, {Safia K.} and Steven Robinson and Okuno, {Scott Heitaka} and Rose, {Peter S.} and Laack, {Nadia N}",
year = "2013",
doi = "10.1155/2013/681425",
language = "English (US)",
volume = "2013",
journal = "Sarcoma",
issn = "1357-714X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Adult ewing sarcoma

T2 - Survival and local control outcomes in 102 patients with localized disease

AU - Ahmed, Safia K.

AU - Robinson, Steven

AU - Okuno, Scott Heitaka

AU - Rose, Peter S.

AU - Laack, Nadia N

PY - 2013

Y1 - 2013

N2 - Objectives. To assess the clinical features and local control (LC) outcomes in adult patients with localized Ewing Sarcoma (ES). Methods. The records of 102 ES patients with localized disease ≥18 years of age seen from 1977 to 2007 were reviewed. Factors relevant to prognosis, survival, and LC were analyzed. Results. The 5-year overall survival (OS) and event-free survival (EFS) were 60% and 52%, respectively, for the entire cohort. Treatment era (1977-1992 versus 1993-2007) remained an independent prognostic factor for OS on multivariate analysis, with improved outcomes observed in the 1993-2007 era (P = 0.02). The 5-year OS and EFS for the 1993-2007 era were 73% and 60%, respectively. Ifosfamide and etoposide based chemotherapy and surgery were more routinely used in the 1993-2007 era (P < 0.01). The 5-year local failure rate (LFR) was 14%, with a 5-year LFR of 18% for surgery, 33% for radiation, and 0% for combined surgery and radiation in the 1993-2007 era (P = 0.17). Conclusion. Modern survival outcomes for adults with localized ES are similar to multi-institutional results in children. This improvement over time is associated with treatment intensification with chemotherapy and increased use of surgery. Aggressive LC (combined surgery and radiation) may improve outcomes in poor prognosis patients.

AB - Objectives. To assess the clinical features and local control (LC) outcomes in adult patients with localized Ewing Sarcoma (ES). Methods. The records of 102 ES patients with localized disease ≥18 years of age seen from 1977 to 2007 were reviewed. Factors relevant to prognosis, survival, and LC were analyzed. Results. The 5-year overall survival (OS) and event-free survival (EFS) were 60% and 52%, respectively, for the entire cohort. Treatment era (1977-1992 versus 1993-2007) remained an independent prognostic factor for OS on multivariate analysis, with improved outcomes observed in the 1993-2007 era (P = 0.02). The 5-year OS and EFS for the 1993-2007 era were 73% and 60%, respectively. Ifosfamide and etoposide based chemotherapy and surgery were more routinely used in the 1993-2007 era (P < 0.01). The 5-year local failure rate (LFR) was 14%, with a 5-year LFR of 18% for surgery, 33% for radiation, and 0% for combined surgery and radiation in the 1993-2007 era (P = 0.17). Conclusion. Modern survival outcomes for adults with localized ES are similar to multi-institutional results in children. This improvement over time is associated with treatment intensification with chemotherapy and increased use of surgery. Aggressive LC (combined surgery and radiation) may improve outcomes in poor prognosis patients.

UR - http://www.scopus.com/inward/record.url?scp=84880144937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880144937&partnerID=8YFLogxK

U2 - 10.1155/2013/681425

DO - 10.1155/2013/681425

M3 - Article

VL - 2013

JO - Sarcoma

JF - Sarcoma

SN - 1357-714X

M1 - 681425

ER -